<?xml version="1.0"?>
<rss version="2.0" xmlns:blogChannel="http://backend.userland.com/blogChannelModule">
	<channel>
		<title>Medscape Diabetes &amp; Endocrinology Headlines</title>
		<link>http://www.medscape.com/diabetes-endocrinology?src=rss</link>
		<description>Latest medical news, articles, and features from Medscape Diabetes &amp; Endocrinology</description>
		<image>
			<url>http://images.medscape.com/pi/global/logos/mscp/logo-medscape110x30.gif</url>
			<title>Medscape Diabetes &amp; Endocrinology Headlines</title>
			<link>http://www.medscape.com/diabetes-endocrinology?src=rss</link>
		</image>
		<language>en-us</language>
		<copyright>Copyright 2009, Medscape</copyright>
		<pubDate>Wed, 25 Nov 2009 06:40:44 EST</pubDate>
		<managingEditor>DiabetesEditor@medscape.net</managingEditor>
		<webMaster>medscapecustomersupport@webmd.net (Medscape Customer Support)</webMaster>

		<item>
			<title>Acute Phosphate Nephropathy</title>
			<link>http://www.medscape.com/viewarticle/712534?src=rss</link>
			<description>Can drinking lots of water and other cautions prevent acute phosphate nephropathy after receiving oral sodium phosphate treatments?  &lt;br /&gt; &lt;i&gt;<![CDATA[Kidney International]]>&lt;/i&gt;</description>
			<category>Nephrology</category>
					<pubDate>Wed, 25 Nov 2009 12:00:00 EST</pubDate>
		</item>
		<item>
			<title>Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)</title>
			<link>http://www.medscape.com/viewarticle/712425?src=rss</link>
			<description>The TREAT trial tested the hypothesis that the use of erythropoiesis-stimulating agents would improve outcomes in patients with diabetes and chronic kidney disease who were also anemic.  &lt;br /&gt; &lt;i&gt;<![CDATA[The American College of Cardiology's Cardiosource]]>&lt;/i&gt;</description>
			<category>Cardiology</category>
					<pubDate>Wed, 25 Nov 2009 12:00:00 EST</pubDate>
		</item>
		<item>
			<title>New Algorithm Predicts Osteoporotic Fractures</title>
			<link>http://www.medscape.com/viewarticle/712958?src=rss</link>
			<description>A new risk prediction algorithm for hip and other fractures from osteoporosis is relatively easy to use and can help primary care clinicians identify patients at high risk.  &lt;br /&gt; &lt;i&gt;<![CDATA[Medscape Medical News]]>&lt;/i&gt;</description>
			<category>Orthopaedics</category>
					<pubDate>Tue, 24 Nov 2009 12:01:42 EST</pubDate>
		</item>
		<item>
			<title>Diabetes, LV Mass Predict Progression From Prehypertension to Hypertension</title>
			<link>http://www.medscape.com/viewarticle/712928?src=rss</link>
			<description>Systolic blood pressure, left ventricular (LV) mass, and diabetes status independently predict the likelihood that prehypertensive patients with cardiac risk factors will develop overt hypertension, according to a report in the November issue of Hypertension.  &lt;br /&gt; &lt;i&gt;<![CDATA[Reuters Health Information]]>&lt;/i&gt;</description>
			<category>Cardiology</category>
					<pubDate>Tue, 24 Nov 2009 11:53:24 EST</pubDate>
		</item>
		<item>
			<title>Triggering With Gonadotropin-Releasing Hormone Agonist in Hyperresponders</title>
			<link>http://www.medscape.com/viewarticle/712620?src=rss</link>
			<description>A commentary on the benefits and risks of triggering ovulation with GnRHa in hyperresponding patients, published October 2009 in Human Reproduction.  &lt;br /&gt; &lt;i&gt;<![CDATA[Medscape Ob/Gyn & Women's Health]]>&lt;/i&gt;</description>
			<category>Ob/Gyn &amp; Women&apos;s Health</category>
					<pubDate>Tue, 24 Nov 2009 11:38:22 EST</pubDate>
		</item>
		<item>
			<title>Serum HCV RNA Levels and HCV Genotype Do Not Affect Insulin Resistance in Nondiabetic Patients With Chronic Hepatitis C: A Multicentre Study</title>
			<link>http://www.medscape.com/viewarticle/711317?src=rss</link>
			<description> This study investigated the viral, metabolic, and histologic predictors of insulin resistance (IR) in patients with chronic HCV.  &lt;br /&gt; &lt;i&gt;<![CDATA[Alimentary Pharmacology & Therapeutics]]>&lt;/i&gt;</description>
			<category>Gastroenterology</category>
					<pubDate>Tue, 24 Nov 2009 12:00:00 EST</pubDate>
		</item>
		<item>
			<title>Bivalirudin Reduces PCI Bleeding in Diabetics</title>
			<link>http://www.medscape.com/viewarticle/712860?src=rss</link>
			<description>Bivalirudin monotherapy is less likely than heparin to cause bleeding in diabetics undergoing percutaneous coronary intervention (PCI), Italian researchers report in the November 1 issue of the American Journal of Cardiology.  &lt;br /&gt; &lt;i&gt;<![CDATA[Reuters Health Information]]>&lt;/i&gt;</description>
			<category>Cardiology</category>
					<pubDate>Mon, 23 Nov 2009 16:05:38 EST</pubDate>
		</item>
		<item>
			<title>High Waist-To-Hip Ratio in Midlife Linked to Later Dementia</title>
			<link>http://www.medscape.com/viewarticle/712834?src=rss</link>
			<description>A high waist-to-hip ratio in mid-life in women is related to an increased risk of dementia later in life, researchers report in the November 10th issue of Neurology.  &lt;br /&gt; &lt;i&gt;<![CDATA[Reuters Health Information]]>&lt;/i&gt;</description>
			<category>Neurology &amp; Neurosurgery</category>
					<pubDate>Mon, 23 Nov 2009 15:33:42 EST</pubDate>
		</item>
		<item>
			<title>FDA Reports Apparent Excess of CV Events With Sibutramine in SCOUT</title>
			<link>http://www.medscape.com/viewarticle/712886?src=rss</link>
			<description>An early analysis for the randomized placebo-controlled trial&apos;s primary end point, a composite of cardiovascular events, found a &quot;higher than expected&quot; rate of increase among those getting the appetite suppressant. The trial enrolled a population with a high CV risk, many of whom would not generally be recommended for the drug according to its current labeling.  &lt;br /&gt; &lt;i&gt;<![CDATA[Heartwire]]>&lt;/i&gt;</description>
			<category>Cardiology</category>
					<pubDate>Mon, 23 Nov 2009 13:54:11 EST</pubDate>
		</item>
		<item>
			<title>More Obesity, Diabetes in South, Appalachia</title>
			<link>http://www.medscape.com/viewarticle/712884?src=rss</link>
			<description>The CDC hopes new data will help target funds for obesity and diabetes.  &lt;br /&gt; &lt;i&gt;<![CDATA[WebMD Health News]]>&lt;/i&gt;</description>
			<category>Diabetes &amp; Endocrinology</category>
					<pubDate>Mon, 23 Nov 2009 13:44:05 EST</pubDate>
		</item>
		<item>
			<title>Alcohol Cuts Risk for Heart Disease by One Third</title>
			<link>http://www.medscape.com/viewarticle/712821?src=rss</link>
			<description>In the European Prospective Investigation into Cancer and Nutrition study, Spanish participants who regularly drank alcohol had a reduced risk for serious heart disease.  &lt;br /&gt; &lt;i&gt;<![CDATA[Medscape Medical News]]>&lt;/i&gt;</description>
			<category>Cardiology</category>
					<pubDate>Fri, 20 Nov 2009 13:58:48 EST</pubDate>
		</item>
		<item>
			<title>Three Major Trials Presented at ASN 2009</title>
			<link>http://www.medscape.com/viewarticle/712645?src=rss</link>
			<description>Jeffrey S. Berns, MD, reports from the floor of ASN Renal Week 2009 on 3 major trials, including an &quot;outstandingly done study&quot; on differing hemoglobin levels in patients with CKD and type 2 diabetes.  &lt;br /&gt; &lt;i&gt;<![CDATA[Medscape Nephrology]]>&lt;/i&gt;</description>
			<category>Nephrology</category>
					<pubDate>Fri, 20 Nov 2009 13:50:30 EST</pubDate>
		</item>
		<item>
			<title>Sen Grassley Questions Top Medical Schools About Ghostwriting</title>
			<link>http://www.medscape.com/viewarticle/712823?src=rss</link>
			<description>As part of his mission to see more financial transparency in medicine, Sen Grassley has asked eight top US medical schools about their policies on ghostwriting.  &lt;br /&gt; &lt;i&gt;<![CDATA[Heartwire]]>&lt;/i&gt;</description>
			<category>Cardiology</category>
					<pubDate>Fri, 20 Nov 2009 13:48:39 EST</pubDate>
		</item>
		<item>
			<title>Hypothyroidism Linked With Specific Memory Deficit</title>
			<link>http://www.medscape.com/viewarticle/712781?src=rss</link>
			<description>Cognitive impairments in patients with hypothyroidism may be related to a disruption in hippocampal processes, according to Irish researchers.  &lt;br /&gt; &lt;i&gt;<![CDATA[Reuters Health Information]]>&lt;/i&gt;</description>
			<category>Diabetes &amp; Endocrinology</category>
					<pubDate>Fri, 20 Nov 2009 13:35:50 EST</pubDate>
		</item>
		<item>
			<title>Sliding Scale Versus Tight Glycemic Control in the Noncritically Ill at a Community Hospital</title>
			<link>http://www.medscape.com/viewarticle/712269?src=rss</link>
			<description>Is sliding scale insulin as effective as tight glycemic control for achieving target range measurements in patients who are not critically ill?  &lt;br /&gt; &lt;i&gt;<![CDATA[The Annals of Pharmacotherapy]]>&lt;/i&gt;</description>
			<category>Pharmacist</category>
					<pubDate>Fri, 20 Nov 2009 12:00:00 EST</pubDate>
		</item>
		<item>
			<title>House Passes Medicare SGR Fix </title>
			<link>http://www.medscape.com/viewarticle/712775?src=rss</link>
			<description>The House passed a bill that would rewrite the controversial sustainable growth rate   formula and eliminate a 21.2% Medicare pay cut for physicians scheduled for 2010.  &lt;br /&gt; &lt;i&gt;<![CDATA[Medscape Medical News]]>&lt;/i&gt;</description>
			<category>Business of Medicine</category>
					<pubDate>Thu, 19 Nov 2009 17:11:22 EST</pubDate>
		</item>
		<item>
			<title>ALLHAT Investigators Report 10-Year Follow-up and Stand by Diuretics as First-Step Antihypertensive Treatment</title>
			<link>http://www.medscape.com/viewarticle/712724?src=rss</link>
			<description>New data confirm the original conclusions: although amlodipine and lisinopril are not superior to chlorthalidone on any outcome, chlorthalidone is superior to them on 1 or more secondary endpoints.  &lt;br /&gt; &lt;i&gt;<![CDATA[Medscape Medical News]]>&lt;/i&gt;</description>
			<category>Neurology &amp; Neurosurgery</category>
					<pubDate>Thu, 19 Nov 2009 12:00:28 EST</pubDate>
		</item>
		<item>
			<title>Alogliptin Safe and Effective for Type 2 Diabetes in Elderly Patients</title>
			<link>http://www.medscape.com/viewarticle/712689?src=rss</link>
			<description>The dipeptidyl peptidase-4 (DPP-4) inhibitor alogliptin (Takeda) is safe and effective for treating type 2 diabetes in elderly patients, according to a report in the November Journal of the American Geriatrics Society.  &lt;br /&gt; &lt;i&gt;<![CDATA[Reuters Health Information]]>&lt;/i&gt;</description>
			<category>Diabetes &amp; Endocrinology</category>
					<pubDate>Thu, 19 Nov 2009 11:57:24 EST</pubDate>
		</item>
		<item>
			<title>Assessment of the Neck and Lymph Nodes in the Elderly Patient</title>
			<link>http://www.medscape.com/viewarticle/712256?src=rss</link>
			<description>Next in this important series on geriatric assessment: examining the neck and lymph nodes.  &lt;br /&gt; &lt;i&gt;<![CDATA[Medscape Family Medicine]]>&lt;/i&gt;</description>
			<category>Family Medicine/Primary Care</category>
					<pubDate>Thu, 19 Nov 2009 09:52:22 EST</pubDate>
		</item>
		<item>
			<title>Urinary Adiponectin Excretion: A Novel Marker for Vascular Damage in Type 2 Diabetes</title>
			<link>http://www.medscape.com/viewarticle/711900?src=rss</link>
			<description>In contrast to existing data on serum adiponectin, this study assesses whether urinary adiponectin excretion might represent a more consistent vascular damage marker in type 2 diabetes.  &lt;br /&gt; &lt;i&gt;<![CDATA[Diabetes]]>&lt;/i&gt;</description>
			<category>Diabetes &amp; Endocrinology</category>
					<pubDate>Thu, 19 Nov 2009 12:00:00 EST</pubDate>
		</item>

</channel>
</rss>